Ibrutix
Ibrutix Uses, Dosage, Side Effects, Mechanism of Action, How Long Does it Take to Work? Ibrutix is a brand name. Its generic name is Ibrutinib.
Introduction
Ibrutix is an oral, cancer chemotherapeutic medication that has been approved since 2013 to treat certain forms of leukaemia and lymphoma. It is a type of drug called a selective inhibitor of Bruton's tyrosine kinase (BTK). BTK helps the body make immune cells, and can cause some types of cancer if it is overactive. Ibrutix blocks the BTK protein, which helps to stop cancer cells from multiplying and spreading to other parts of the body.Uses
Ibrutix is used to treat mantle cell lymphoma, chronic lymphocytic leukemia, Waldenström's macroglobulinemia, marginal zone lymphoma, and small lymphocytic lymphoma. It may be prescribed as a single agent or in combination with other chemotherapeutic drugs.Mechanism of Action
Ibrutix works by blocking a protein called Bruton's tyrosine kinase (BTK). BTK helps the body make immune cells, and can be overactive in a certain type of cancer. By blocking BTK, ibrutinib stops cancer cells from multiplying and spreading to other parts of the body.How Long Does It Take to Work?
Ibrutix is generally well-tolerated and begins working quickly. Evidence suggests that the drug begins to work within days to weeks of first use, although some patients may experience an increase in their symptoms before they begin to feel better. Factors such as age, other medical conditions, and drug interactions may slow down the effectiveness of the drug.Absorption
Ibrutix is absorbed quickly when taken orally. Studies have found that its bioavailability is approximately 90%. It is thought that its high bioavailability is due to its ability to bypass first-pass metabolic degradation in the liver.Route of Elimination
Ibrutix is eliminated through both hepatic metabolism and urinary excretion. The major metabolic pathway involves the Cyp3A4 isoenzyme, which is responsible for metabolizing approximately 70% of the drug. The remaining 30% is eliminated unchanged in the urine.Dosage
The recommended starting dose for ibrutinib is 560 mg or 420 mg daily, depending on the indication. For adults, the dose may be increased to 840 mg daily. Patients should take the medication with a meal. It is important to follow your doctor’s instructions on how to take this medication.Administration
Ibrutix is administered orally, usually in capsule form. It should be taken with a meal, and should not be chewed, crushed, or split. It is important to follow your doctor’s instructions on how to take this medication.Side Effects
Common side effects of ibrutinib include diarrhea, fatigue, nausea, and muscle and joint pain. Other side effects include hypertension, neutropenia, increased bleeding risk, and edema. Ibrutix may also increase the risk of certain types of cancer. It is important to discuss the potential risks and side effects of ibrutinib with your doctor before starting treatment.Toxicity
Ibrutix has a low potential for toxicity. Studies have shown that it is not nephrotoxic, hepatotoxic, or teratogenic. It is important to discuss the potential for toxicity with your doctor before starting treatment.Precaution
Patients taking ibrutinib should be monitored for safety and efficacy throughout the course of treatment. Patients should also receive routine blood tests to monitor for side effects. It is important to follow your doctor’s instructions and adhere to recommended dosing schedules.Interaction
Ibrutix may interact with other drugs, including certain antibiotics, antivirals, antifungals, and anticoagulants. It may also interact with certain supplements and herbal products. It is important to tell your doctor about all medications you are taking before starting ibrutinib.Disease Interaction
Ibrutix may interact with certain diseases, including renal impairment, hepatic impairment, and coagulopathy. It should not be used in patients with active infections, as it may worsen the infection.Drug Interaction
Ibrutix may interact with certain drugs, including some antibiotics, antivirals, antifungals, and anticoagulants. It is important to tell your doctor about all medications you are taking before starting ibrutinib.Food Interactions
Ibrutix should be taken with food. It should not be taken with grapefruit and grapefruit juice, as these can increase the concentration of Ibrutix in the blood. It is important to follow your doctor's instructions when taking this medication.Pregnancy Use
Ibrutix is classified as a Pregnancy Category D medication, meaning that it may cause harm to the fetus if taken during pregnancy. It should not be used in pregnant women, and women of childbearing age should use an effective form of birth control while taking this medication.Lactation Use
Ibrutix is excreted in breast milk, and may cause harm to a breastfeeding infant. It should not be used in nursing mothers, or women who are breastfeeding.Acute Overdose
It is important to follow your doctor’s instructions when taking Ibrutix. If an overdose is suspected, seek emergency medical attention. Symptoms of an overdose may include nausea, vomiting, abdominal pain, and diarrhea.Contraindication
Ibrutix should not be used in patients with a known allergy to the drug. It should also not be used in patients with active infections.Use Direction
Ibrutix should be taken orally, usually in pill form with food. It should be taken at the same time every day, as prescribed by your doctor. It is important to follow your doctor’s instructions when taking this medication.Storage Condition
Ibrutix should be stored at room temperature, away from moisture and light. Keep the medication in a tightly closed container. Do not store in the bathroom.Volume of Distribution
Ibrutix has a volume of distribution of approximately 50 L, indicating it distributes throughout the body.Half Life
Ibrutix has an elimination half-life of approximately 15 hours. This indicates that it takes 15 hours for the drug’s concentration in the body to be reduced to half its initial value.Clearance
Ibrutix has a clearance of approximately 34 L/h, indicating it is eliminated from the body at a rate of 34 liters per hour.Here you find in details version of Ibrutix
Some Frequently Asked Questions About Ibrutix
https://www.medicinesfaq.com/brand/ibrutix,
,
,
https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:76612,
http://www.genome.jp/dbget-bin/www_bget?drug:D10223,
https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=24821094,
https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=310264995,
https://www.chemspider.com/Chemical-Structure.26637187.html,
http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50357312,
https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1442981,
https://www.ebi.ac.uk/chebi/searchId.do?chebiId=76612,
https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL1873475,
https://zinc.docking.org/substances/ZINC000035328014,
http://www.pharmgkb.org/drug/PA166121346,
https://www.ebi.ac.uk/pdbe-srv/pdbechem/chemicalCompound/show/1E8,
https://www.drugs.com/imbruvica.html,
https://en.wikipedia.org/wiki/Ibrutinib,